Ashley Cordova Biography and Net Worth

CFO of NovoCure

Ashley Cordova has served as Novocure’s Chief Financial Officer since September 2020. She is responsible for the oversight of Novocure’s global financial operations, including financial reporting, financial planning and analysis, treasury, tax, and investor relations.

From October 2018 to August 2020, Ms. Cordova served as the Company’s Senior Vice President, Finance and Investor Relations. Ms. Cordova joined the Company in June 2014 as Director of Global Treasury. In March 2015, she became the Company’s Senior Director, Investor Relations and Global Treasury, and in July 2016, she became the Company’s Vice President, Finance and Investor Relations. Prior to joining Novocure, Ms. Cordova served in various financial roles at Zoetis Inc. from 2012 to 2014 and Pfizer Inc. from 2005 to 2012. Ms. Cordova graduated with a bachelor’s degree in Music and Business from Furman University, and earned her International Master of Business Administration from the University of South Carolina.

What is Ashley Cordova's net worth?: The estimated net worth of Ashley Cordova is at least $5.15 million as of September 5th, 2025. Ms. Cordova owns 437,569 shares of NovoCure stock worth more than $5,145,811 as of December 4th. This net worth approximation does not reflect any other assets that Ms. Cordova may own. Additionally, Ms. Cordova receives an annual salary of $814,810.00 as CFO at NovoCure. Learn More about Ashley Cordova's net worth.
How old is Ashley Cordova?: Ms. Cordova is currently 45 years old. There are 7 older executives and no younger executives at NovoCure. The oldest executive at NovoCure is Prof. Yoram Palti M.D., Ph.D., Founder & CTO, who is 86 years old. Learn More on Ashley Cordova's age.
What is Ashley Cordova's salary?: As the CFO of NovoCure Limited, Ms. Cordova earns $814,810.00 per year. There are 3 executives that earn more than Ms. Cordova. The highest earning executive at NovoCure is Mr. Asaf Danziger, CEO & Director, who commands a salary of $1,520,000.00 per year. Learn More on Ashley Cordova's salary.
How do I contact Ashley Cordova?: The corporate mailing address for Ms. Cordova and other NovoCure executives is NO. 4 THE FORUM GRENVILLE STREET, ST. HELIER Y9, JE2 4UF. NovoCure can also be reached via phone at 441534756700 and via email at [email protected]. Learn More on Ashley Cordova's contact information.
Has Ashley Cordova been buying or selling shares of NovoCure?: Ashley Cordova has not been actively trading shares of NovoCure within the last three months. Most recently, on Friday, September 5th, Ashley Cordova bought 81,550 shares of NovoCure stock. The stock was acquired at an average cost of $12.22 per share, with a total value of $996,541.00. Following the completion of the transaction, the chief executive officer now directly owns 437,569 shares of the company's stock, valued at $5,347,093.18. Learn More on Ashley Cordova's trading history.
Who are NovoCure's active insiders?: NovoCure's insider roster includes Michael Ambrogi (COO), Ely Benaim (Insider), Christoph Brackmann (CFO), Ashley Cordova (CFO), Asaf Danziger (CEO), William Doyle (Executive Chairman), Wilhelmus Groenhuysen (COO), Jeryl Hilleman (Director), Frank Leonard (Insider), Gabriel Leung (Director), Todd Longsworth (General Counsel), Martin Madden (Director), Mukund Paravasthu (COO), Michael Puri (Insider), Pritesh Shah (Insider), William Vernon (Director), and Uri Weinberg (Insider). Learn More on NovoCure's active insiders.
Are insiders buying or selling shares of NovoCure?: During the last twelve months, NovoCure insiders bought shares 2 times. They purchased a total of 101,550 shares worth more than $1,228,341.00. The most recent insider tranaction occured on September, 5th when CEO Ashley Cordova bought 81,550 shares worth more than $996,541.00. Insiders at NovoCure own 5.5% of the company. Learn More about insider trades at NovoCure.
Information on this page was last updated on 9/5/2025.

Ashley Cordova Insider Trading History at NovoCure

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/5/2025	Buy	81,550	$12.22	$996,541.00	437,569
8/2/2024	Sell	688	$20.14	$13,856.32	219,179
9/1/2023	Sell	883	$21.82	$19,267.06	99,650
3/1/2023	Sell	2,198	$76.36	$167,839.28	96,062
3/8/2022	Sell	759	$70.10	$53,205.90
3/3/2022	Sell	1,149	$74.50	$85,600.50
9/2/2021	Sell	828	$138.23	$114,454.44
8/12/2021	Sell	26,624	$140.94	$3,752,386.56	45,993
11/2/2020	Sell	230	$117.41	$27,004.30	26,212

Ashley Cordova Buying and Selling Activity at NovoCure

NovoCure Company Overview

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Today's Range

Now: $11.76

$11.36

$11.83

50 Day Range

MA: $12.79

$10.92

$14.66

2 Week Range

Now: $11.76

$10.70

$34.13

Volume

1,787,299 shs

Average Volume

1,797,449 shs

Market Capitalization

$1.32 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.83

Ashley Cordova Biography and Net Worth

What is Ashley Cordova's net worth?

How old is Ashley Cordova?

What is Ashley Cordova's salary?

How do I contact Ashley Cordova?

Has Ashley Cordova been buying or selling shares of NovoCure?

Who are NovoCure's active insiders?

Are insiders buying or selling shares of NovoCure?